XOMA Royalty Completes Acquisition of Generation Bio Co.; Shares Delisted

summarizeSummary

XOMA Royalty Corporation has successfully completed its tender offer and acquisition of Generation Bio Co., which is now a wholly-owned subsidiary and has ceased trading on Nasdaq.

check_boxKey Events

• Acquisition Completed

  XOMA Royalty Corporation successfully completed its tender offer and acquired Generation Bio Co. on February 9, 2026.

• Delisting from Nasdaq

  Generation Bio Co. shares ceased trading on Nasdaq on February 6, 2026, and the company has requested delisting and deregistration.

• Becomes Wholly-Owned Subsidiary

  Generation Bio Co. is now a wholly-owned subsidiary of XOMA Royalty Corporation following the merger.

• Tender Offer Results

  Approximately 70% of Generation Bio Co. shares were validly tendered and accepted at $4.2913 cash plus one contingent value right (CVR) per share.

auto_awesomeAnalysis

This filing marks the definitive completion of the acquisition of Generation Bio Co. by XOMA Royalty Corporation, following a tender offer initiated on January 9, 2026. With approximately 70% of shares tendered, all conditions were met, leading to the merger and Generation Bio becoming a wholly-owned subsidiary. This event is critical as it results in the delisting of Generation Bio's common stock from Nasdaq, fundamentally altering the investment thesis for shareholders.